Quinapril Hydrochloride Tablet
Lupin Pharmaceuticals, Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 01/19/2023
- Package NDC
- 68180-554-09
- Generic name
- Quinapril Hydrochloride Tablet
- Contact info
- 866-587-4617
- Availability
- Unavailable
- Related info
- Estimated recovery: TBD
- Update date
- 09/01/2026
- Dosage form
- Tablet
- Presentation
- Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)
- Company name
- Lupin Pharmaceuticals, Inc.
- Shortage reason
- Requirements related to complying with good manufacturing practices
- Status
- Current
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- ANDA077690
- Brand name
- QUINAPRIL
- Generic name
- QUINAPRIL
- Manufacturer name
- Lupin Pharmaceuticals, Inc.
- Product NDC
- 68180-554, 68180-556, 68180-557, 68180-558, 68180-559
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- QUINAPRIL HYDROCHLORIDE
- RxCUI
- 312748, 312749, 312750, 314203
- SPL ID
- a9598a21-6f99-4c86-ace6-b5638da2bec8
- SPL set ID
- 8ded0773-3aec-4e89-9836-d22a5a84abf0
- Package NDC
- 68180-556-09, 68180-557-09, 68180-557-03, 68180-558-09, 68180-558-03, 68180-554-09, 68180-554-03, 68180-559-03, 68180-559-09
- UNII
- 33067B3N2M